This report describes and explains the drugs of abuse (DOA) testing market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global drugs of abuse (DOA) testing market reached a value of nearly $7.29 billion in 2024, having grown at a compound annual growth rate (CAGR) of 6.24% since 2019. The market is expected to grow from $7.29 billion in 2024 to $11.31 billion in 2029 at a rate of 9.17%. The market is then expected to grow at a CAGR of 8.46% from 2029 and reach $16.98 billion in 2034.
Growth in the historic period resulted from increasing consumption of alcohol, rising drug abuse cases, increase in forensic and criminal investigations and rise in workplace safety concerns. Factors that negatively affected growth in the historic period were infrastructure and regulatory challenges and lack of standardization.
Going forward, growing healthcare awareness, rise in road safety concerns, rise in drug smuggling and trafficking and expansion of rehabilitation and treatment centers. Factor that could hinder the growth of the drugs of abuse (DOA) testing market in the future include high costs of advanced testing equipment and risk of false positives and negatives.
North America was the largest region in the drugs of abuse (DOA) testing market, accounting for 43.64% or $3.18 billion of the total in 2024. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the drugs of abuse (DOA) testing market will be Asia-Pacific, Eastern Europe where growth will be at CAGRs of 13.54% and 10.45% respectively. These will be followed by South America and Middle East where the markets are expected to grow at CAGRs of 9.79% and 9.17% respectively.
The global drugs of abuse (DOA) testing market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 43.59% of the total market in 2023. Abbott Laboratories was the largest competitor with a 6.28% share of the market, followed by Danaher Corporation with 5.48%, Laboratory Corporation of America Holdings with 5.39%, Quest Diagnostics Inc. with 5.14%, Thermo Fisher Scientific Inc. with 4.98%, F. Hoffmann-La Roche Ltd. with 3.69%, Drägerwerk AG & Co. KGaA with 3.64%, Siemens Healthneers with 3.64%, Bio-Rad Laboratories Inc. with 3.37% and Agilent Technologies Inc. with 1.98%.
The drugs of abuse (DOA) testing market is segmented by product and service into analyzers, rapid testing devices, consumables and laboratory services. The consumables market was the largest segment of the drugs of abuse (DOA) testing market segmented by product and service, accounting for 40.05% or $2.92 billion of the total in 2024. Going forward, the analyzers segment is expected to be the fastest growing segment in the drugs of abuse (DOA) testing market segmented by product and service, at a CAGR of 10.43% during 2024-2029.
The drugs of abuse (DOA) testing market is segmented by sample type into urine, hair, oral fluid, breath and other sample types. The urine market was the largest segment of the drugs of abuse (DOA) testing market segmented by sample type, accounting for 35.19% or $2.56 billion of the total in 2024. Going forward, the hair segment is expected to be the fastest growing segment in the drugs of abuse (DOA) testing market segmented by sample type, at a CAGR of 11.65% during 2024-2029.
The drugs of abuse (DOA) testing market is segmented by application into pain management, criminal justice and workplace screening. The pain management market was the largest segment of the drugs of abuse (DOA) testing market segmented by application, accounting for 41.87% or $3.05 billion of the total in 2024. Going forward, the criminal justice segment is expected to be the fastest growing segment in the drugs of abuse (DOA) testing market segmented by application, at a CAGR of 10.51% during 2024-2029.
The drugs of abuse (DOA) testing market is segmented by end-user into hospitals, diagnostic laboratories, forensic laboratories and other end users. The hospitals market was the largest segment of the drugs of abuse (DOA) testing market segmented by end-user, accounting for 32.04% or $2.33 billion of the total in 2024. Going forward, the forensic laboratories segment is expected to be the fastest growing segment in the drugs of abuse (DOA) testing market segmented by end-user, at a CAGR of 10.47% during 2024-2029.
The top opportunities in the drugs of abuse (DOA) testing markets segmented by product and service will arise in the consumables segment, which will gain $1.62 billions of global annual sales by 2029. The top opportunities in the drugs of abuse (DOA) testing markets segmented by sample type will arise in the urine segment, which will gain $1.27 billions of global annual sales by 2029. The top opportunities in the drugs of abuse (DOA) testing markets segmented by application will arise in the pain management segment, which will gain $1.64 billions of global annual sales by 2029. The top opportunities in the drugs of abuse (DOA) testing markets segmented by end-user will arise in the hospitals segment, which will gain $1.4 billions of global annual sales by 2029. The drugs of abuse (DOA) testing market size will gain the most in the USA at $1.17 billion.
Market-trend-based strategies for the drugs of abuse (DOA) testing market include development of innovative solutions, such as mass spec solutions, development of innovative solutions, such as drugs of abuse reagents, to improve the accuracy, speed, and reliability of drug screening tests and focus on developing innovative solutions, such as urine drugs of abuse testing.
Player-adopted strategies in the drugs of abuse (DOA) testing market include focus on expanding operational capabilities through strategic partnerships and strategic investments.
To take advantage of the opportunities, the analyst recommends the drugs of abuse (DOA) testing focus on mass spectrometry integration to enhance testing accuracy, focus on developing innovative reagents for field-deployable testing, focus on enhancing urine drug testing solutions, focus on the analyzers market segment, expand in emerging markets, continue to focus on developed markets, focus on developing competitive and value-based pricing strategies, focus on targeting key industries and increasing awareness of DOA testing products, focus on educational content and long-term partnerships for brand loyalty, focus on forensic laboratories for targeting drug of abuse testing.
The global drugs of abuse (DOA) testing market reached a value of nearly $7.29 billion in 2024, having grown at a compound annual growth rate (CAGR) of 6.24% since 2019. The market is expected to grow from $7.29 billion in 2024 to $11.31 billion in 2029 at a rate of 9.17%. The market is then expected to grow at a CAGR of 8.46% from 2029 and reach $16.98 billion in 2034.
Growth in the historic period resulted from increasing consumption of alcohol, rising drug abuse cases, increase in forensic and criminal investigations and rise in workplace safety concerns. Factors that negatively affected growth in the historic period were infrastructure and regulatory challenges and lack of standardization.
Going forward, growing healthcare awareness, rise in road safety concerns, rise in drug smuggling and trafficking and expansion of rehabilitation and treatment centers. Factor that could hinder the growth of the drugs of abuse (DOA) testing market in the future include high costs of advanced testing equipment and risk of false positives and negatives.
North America was the largest region in the drugs of abuse (DOA) testing market, accounting for 43.64% or $3.18 billion of the total in 2024. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the drugs of abuse (DOA) testing market will be Asia-Pacific, Eastern Europe where growth will be at CAGRs of 13.54% and 10.45% respectively. These will be followed by South America and Middle East where the markets are expected to grow at CAGRs of 9.79% and 9.17% respectively.
The global drugs of abuse (DOA) testing market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 43.59% of the total market in 2023. Abbott Laboratories was the largest competitor with a 6.28% share of the market, followed by Danaher Corporation with 5.48%, Laboratory Corporation of America Holdings with 5.39%, Quest Diagnostics Inc. with 5.14%, Thermo Fisher Scientific Inc. with 4.98%, F. Hoffmann-La Roche Ltd. with 3.69%, Drägerwerk AG & Co. KGaA with 3.64%, Siemens Healthneers with 3.64%, Bio-Rad Laboratories Inc. with 3.37% and Agilent Technologies Inc. with 1.98%.
The drugs of abuse (DOA) testing market is segmented by product and service into analyzers, rapid testing devices, consumables and laboratory services. The consumables market was the largest segment of the drugs of abuse (DOA) testing market segmented by product and service, accounting for 40.05% or $2.92 billion of the total in 2024. Going forward, the analyzers segment is expected to be the fastest growing segment in the drugs of abuse (DOA) testing market segmented by product and service, at a CAGR of 10.43% during 2024-2029.
The drugs of abuse (DOA) testing market is segmented by sample type into urine, hair, oral fluid, breath and other sample types. The urine market was the largest segment of the drugs of abuse (DOA) testing market segmented by sample type, accounting for 35.19% or $2.56 billion of the total in 2024. Going forward, the hair segment is expected to be the fastest growing segment in the drugs of abuse (DOA) testing market segmented by sample type, at a CAGR of 11.65% during 2024-2029.
The drugs of abuse (DOA) testing market is segmented by application into pain management, criminal justice and workplace screening. The pain management market was the largest segment of the drugs of abuse (DOA) testing market segmented by application, accounting for 41.87% or $3.05 billion of the total in 2024. Going forward, the criminal justice segment is expected to be the fastest growing segment in the drugs of abuse (DOA) testing market segmented by application, at a CAGR of 10.51% during 2024-2029.
The drugs of abuse (DOA) testing market is segmented by end-user into hospitals, diagnostic laboratories, forensic laboratories and other end users. The hospitals market was the largest segment of the drugs of abuse (DOA) testing market segmented by end-user, accounting for 32.04% or $2.33 billion of the total in 2024. Going forward, the forensic laboratories segment is expected to be the fastest growing segment in the drugs of abuse (DOA) testing market segmented by end-user, at a CAGR of 10.47% during 2024-2029.
The top opportunities in the drugs of abuse (DOA) testing markets segmented by product and service will arise in the consumables segment, which will gain $1.62 billions of global annual sales by 2029. The top opportunities in the drugs of abuse (DOA) testing markets segmented by sample type will arise in the urine segment, which will gain $1.27 billions of global annual sales by 2029. The top opportunities in the drugs of abuse (DOA) testing markets segmented by application will arise in the pain management segment, which will gain $1.64 billions of global annual sales by 2029. The top opportunities in the drugs of abuse (DOA) testing markets segmented by end-user will arise in the hospitals segment, which will gain $1.4 billions of global annual sales by 2029. The drugs of abuse (DOA) testing market size will gain the most in the USA at $1.17 billion.
Market-trend-based strategies for the drugs of abuse (DOA) testing market include development of innovative solutions, such as mass spec solutions, development of innovative solutions, such as drugs of abuse reagents, to improve the accuracy, speed, and reliability of drug screening tests and focus on developing innovative solutions, such as urine drugs of abuse testing.
Player-adopted strategies in the drugs of abuse (DOA) testing market include focus on expanding operational capabilities through strategic partnerships and strategic investments.
To take advantage of the opportunities, the analyst recommends the drugs of abuse (DOA) testing focus on mass spectrometry integration to enhance testing accuracy, focus on developing innovative reagents for field-deployable testing, focus on enhancing urine drug testing solutions, focus on the analyzers market segment, expand in emerging markets, continue to focus on developed markets, focus on developing competitive and value-based pricing strategies, focus on targeting key industries and increasing awareness of DOA testing products, focus on educational content and long-term partnerships for brand loyalty, focus on forensic laboratories for targeting drug of abuse testing.
Major Market Trends
- Revolutionizing Drug Testing With Mass Spec Solution for Enhanced Accuracy and Efficiency
- Innovative Drugs of Abuse Reagents Enhance Accuracy and Portability in Testing
- Expansion of Urine Drugs of Abuse Testing for Enhanced Accuracy and Rapid Detection
Key Mergers and Acquisitions
- Premier Biotech Inc., Acquired Desert Tox LLC
- Aegis Sciences Corporation Acquires Healthtrackrx’s Toxicology Business
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Major Market Trends
8 Global Drugs of Abuse (DOA) Testing Growth Analysis and Strategic Analysis Framework
9 Global Drugs of Abuse (DOA) Testing Market Segmentation
10 Drugs of Abuse (DOA) Testing Market, Regional and Country Analysis
11 Asia-Pacific Market
12 Western Europe Market
13 Eastern Europe Market
14 North America Market
15 South America Market
16 Middle East Market
17 Africa Market
18 Competitive Landscape and Company Profiles
19 Other Major and Innovative Companies
22 Key Mergers and Acquisitions
23 Recent Developments in the Drugs of Abuse Testing Market
24 Opportunities and Strategies
25 Drugs of Abuse (DOA) Testing Market, Conclusions and Recommendations
26 Appendix
Executive Summary
Drugs of Abuse (DOA) Testing Global Market Opportunities and Strategies to 2034 provides the strategists; marketers and senior management with the critical information they need to assess the global drugs of abuse (DOA) testing market.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for drugs of abuse (DOA) testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (DOA) testing market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider drugs of abuse (DOA) testing market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product and service, by sample type, by application and by end-user.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis and Strategic Analysis - Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size and Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods
- Regional and Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product and service, by sample type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market - Size and Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major and Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard - Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments - Information on recent developments in the market covered in the report.
- Market Opportunities and Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations - This section includes recommendations for drugs of abuse (DOA) testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) by Product and Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services2) by Sample Type: Urine; Hair; Oral Fluid; Breath; Other Sample Types
3) by Application: Pain Management; Criminal Justice; Workplace Screening
4) by End User: Hospitals; Diagnostics Laboratories; Forensic Laboratories; Other End Users
Key Companies Profiled: Abbott Laboratories; Danaher Corporation (Beckman Coulter); Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; Thermo Fisher Scientific Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drugs of abuse (DOA) testing indicators comparison.
Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
The companies featured in this Drugs of Abuse (DOA) Testing market report include:- Abbott Laboratories
- Danaher Corporation (Beckman Coulter)
- Laboratory Corporation of America Holdings
- Quest Diagnostics Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Drägerwerk AG & Co. KGaA
- Siemens Healthneers
- Bio-Rad Laboratories Inc.
- Agilent Technologies Inc.
- Rigaku Analytical Devices
- Hangzhou Realy Tech Co., Ltd.
- Shanghai Kehua Bio-Engineering Co., Ltd.
- Cansford Laboratories
- MIP Discovery
- Randox Laboratories
- Alere Inc
- BioGnost Ltd
- Omega Laboratories
- Premier Biotech Inc
- Desert Tox LLC
- Atlas Medical
- Bloodoxy
- SPINREACT
- InTec Products Inc
- Intelligent Bio Solutions Inc. (INBS)
- Psychemedics Corporation
- Diagnósticos da América S.A. (DASA)
- Beckman Coulter
- Omega Laboratories
- Prometheus Bio Inc.
- Screen4
- Meridian Bioscience
- Randox
- Chromsystems
- ABOUND Diagnostics, Inc
- LabCE
- AlphaBiolabs
- Bloodoxy
- Atlas Medical
- Chromsystems
- ABOUND Diagnostics, Inc
- LabCE
- AlphaBiolabs
- Anatech Instruments
- Meridian Bioscience
- Randox
- ALCO-SAFE
- UberTest
- JAL Medical
- Mokshy Surgical
- QuidelOrthodl
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 325 |
| Published | June 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 7.29 Billion |
| Forecasted Market Value ( USD | $ 16.98 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 53 |
